24-hour urinary sodium excretion
Biomarker1 paper1 finding
- Human trial1
Interventions
1Empagliflozin
upin humans1Low certainty
1 study
Empagliflozin
upin humans1Low certainty
Empagliflozin increases 24-hour urinary sodium excretion in humans (+92.1 mmol/24 h (95%CI: 47.1-137.2)).
Human trialtype 2 diabetes, decompensated cirrhosis, and refractory ascites10 mg once daily10 daysn = 21
Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study · Journal of gastrointestinal and liver diseases : JGLD · 26 Sep 2026
Latest
1Journal of Gastrointestinal and Liver DiseasesHuman trial